Latest Clinical trial Stories

Novum to Open State-of-the-Art Clinical Research Facility in Houston, TX

2013-04-05 12:24:34

HOUSTON, April 5, 2013 /PRNewswire/ -- Novum Pharmaceutical Research Services, a leading contract research organization (CRO) serving the pharmaceutical industry in Phase I-Phase IV clinical trials and related services, announced today the opening of a new early-stage clinical facility in Houston, TX. The 55,000 square foot facility is scheduled to be operational in August, 2013. "This exciting new facility reflects Novum's continued growth and our deep commitment to our clients'...

Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD334 for Autoimmune Diseases

2013-04-05 08:23:08

SAN DIEGO, April 5, 2013 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today the initiation of dosing in a Phase 1 clinical trial of APD334, a novel oral drug candidate that targets the sphingosine 1-phosphate subtype 1 (S1P(1)) receptor for the potential treatment of autoimmune diseases. This randomized, double-blind and placebo-controlled Phase 1 trial will evaluate the safety, tolerability and pharmacokinetics of single-ascending doses of APD334 in up to 64...

VG Life Sciences Reports Positive Safety Results from Second Cohort Enrollment in Solid Tumor Clinical Trial

2013-04-04 08:28:47

Now Enrolling Patients into Third Dosing Cohort SAN MARINO, Calif., April 4, 2013 /PRNewswire/ -- VG Life Sciences, Inc. (OTC Pink: VGLS), a biotechnology company focused on leveraging its innovative platform technologies for the discovery and development of drug therapies for cancer, infectious disease, and inflammation, announced today positive results from stage two of its Pre-IND Phase I Study to test tolerability and toxicity in patients with advanced stage solid tumors. The...

PharmaSeek Implements Allegro CTMS for Clinical Research Site Management

2013-04-04 04:20:56

MADISON, Wis., April 4, 2013 /PRNewswire/ -- Forte Research Systems, Inc., developer of specialized clinical research management software, announced that PharmaSeek, an Investigative Site Network, has implemented its Allegro Clinical Trial Management System (CTMS) to support their rapidly growing operations and help manage multiple trials running simultaneously. The investigative site network switched to the CTMS when they outgrew their existing system. (Logo:...

WIRB-Copernicus Group Thought Leaders Tapped for Key Roles at 2013 AAHRPP Conference

2013-04-03 16:24:08

Jeffrey A. Cooper, MD, MMM, and Carrie Fisher, PhD, MBA, of The WIRB-Copernicus Group Invited to Speak at the International Conference of The Association for the Accreditation of Human Research Protection Programs (AAHRPP) in Miami, Florida PRINCETON, N.J., April 3, 2013 /PRNewswire/ -- The WIRB-Copernicus Group, the world's largest provider of regulatory and ethical review services for human research, announced today that Jeffrey A. Cooper, MD, MMM, Vice President of Global...

Blanchette Rockefeller Neurosciences Institute Partners with Neurotrope BioScience to Advance New Alzheimer's Disease Discoveries

2013-04-03 12:29:19

Human Clinical Trials to Begin MORGANTOWN, W.Va., April 3, 2013 /PRNewswire/ -- The Blanchette Rockefeller Neurosciences Institute (BRNI) at West Virginia University has entered into a strategic Joint Product Development and Commercialization Agreement with Neurotrope BioScience in the field of neurodegenerative disease. The central focus of this collaboration will be to advance novel diagnostic and therapeutic technologies developed at BRNI that have shown exceptional promise in...

Applied Clinical Trials Magazine Advises Clinical Trials to Put Patients First in New Peer-Reviewed Article

2013-04-03 08:26:16

ISELIN, N.J., April 3, 2013 /PRNewswire/ -- Clinical trials are the cornerstone of getting biopharmaceuticals approved to treat diseases now and develop new medicines and knowledge for the future. Many people are unfamiliar with clinical trials until they or a loved one face a life-or-death disease diagnosis. Then the choices to treat their condition become more confusing and urgent. This is true even for professionals who work in and understand clinical trials. In Applied Clinical...

Perceptive Informatics Improves Clinical Trial Management With New Release Of IMPACT® CTMS Solution

2013-04-03 08:24:31

eClinical leader advances clinical trial management system for utmost flexibility and configurability BOSTON, April 3, 2013 /PRNewswire/ -- Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), today released an enhanced version of its comprehensive IMPACT® clinical trial management system (CTMS). Notable features include improved data entry as well as site management and monitoring capabilities. The...

SynteractHCR Appoints Bill Pierce as Chief Information Officer and Richard Paul as Chief Medical Officer and Vice President Medical/Regulatory Affairs

2013-04-02 12:27:55

- New executives will play key roles in company's growth in 2013- SAN DIEGO, April 2, 2013 /PRNewswire/ -- SynteractHCR, a leading full-service contract research organization (CRO), has hired two new senior executives to support the company's growth on a global scale following its recent merger. SynteractHCR has appointed Bill Pierce as chief information officer and Richard Paul as chief medical officer and vice president medical/regulatory affairs. Both were chosen for their...

Adenosine Therapeutics Engages Needham & Company to Explore Strategic Options for Phase III Cardiac Stress Agent

2013-04-01 12:26:11

CHARLOTTESVILLE, Va., April 1, 2013 /PRNewswire/ -- Adenosine Therapeutics, LLC, a drug discovery and development company founded in 1999, announced today that it has engaged Needham & Company to explore strategic options for Stedivaze®, a highly selective adenosine A2A agonist being developed as a pharmacological stress agent for use in Myocardial Perfusion Imaging. "We are seeking regional or global collaborators to rapidly conclude our Phase 3 clinical trials, which are more...